The US pharmaceutical trade association (PhRMA) asked CRA to identify concrete evidence-based proposals on market reforms aimed at creating a more competitive ‘off-patent’ sector in order to generate savings for the Italian National Health Services (SSN).
Working with industry participants, we assessed the potential policy alternatives based on an assessment of the economic and the political realities of the Italian market. This resulted in five potential policy options ranging from tougher enforcement of current generic policy to reforming the incentives for different distribution.
100 days. 14 executive orders. Some bold healthcare policies.
In this CRA Insights, we assess the actions and impact of the second Trump Administration during the first 100 days that directly affect healthcare policy,...